ArticleEuropean radiology2023
Contrast-enhanced mammography-guided biopsy: why, when, and where we need it.
Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 10 citations in OpenAlex.
- Improving the malignancy prediction of breast cancer based on the integration of radiomics features from dual-view mammography and clinical parameters.Clinical and experimental medicine · 2023Trial
- Practical Guide to Percutaneous Biopsy with Contrast-Enhanced Mammography: From Planning to Post-Procedural Management.Diagnostics (Basel, Switzerland) · 2026Review
- 조영증강 유방촬영술: 현재의 임상적 활용과 미래 방향에 대한 종합적 고찰.Journal of the Korean Society of Radiology · 2025Review
- Contrast-Enhanced Mammography-Guided Biopsy in Patients with Extensive Suspicious Microcalcifications.Cancers · 2025Article
- Evaluation of contrast-enhanced mammography (CEM) in the preoperative staging of breast cancer: large-scale single center experience, update to 1005 cases.La Radiologia medica · 2025Article
- Contrast-enhanced mammography-guided biopsy: Is it safe to be implemented in clinical practice?European radiology · 2025Article
- State-of-the-art for contrast-enhanced mammography.The British journal of radiology · 2024Review
- Contrast Enhanced Mammography (CEM) Enhancing Asymmetry: Single-Center First Case Analysis.Diagnostics (Basel, Switzerland) · 2023Article
Corrections and comments
- Comment on
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
key points• The use of CEM-guided biopsy is spreading after initial experiences in a few pilot centers.• CEM-guided biopsy has the potential to ensure fast, low-cost, and effective tissue sampling of MRI-detected and CEM-detected lesions that do not have a corresponding finding at morphological imaging.• The need and utility of CEM-guided biopsy are warranted by the impending expansion of morpho-functional imaging towards breast cancer screening for women with extremely dense breasts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.